Drusen: NBEO and OKAP Essentials

Master drusen size, morphology, AMD risk and AREDS2 criteria for NBEO and OKAP exam questions.

Reviewed for accuracyAugust 2, 20262 min read

Warm-up

In AMD, which drusen characteristic most strongly suggests greater risk of progression compared with normal aging changes?

Lesson

Drusen in 30 Seconds

Drusen are extracellular deposits located between the retinal pigment epithelium and Bruch's membrane that anchor early and intermediate AMD assessment. For NBEO and OKAP, identify their size, margins and confluence. Large soft lesions carry greater progression risk than small hard lesions.

Types and Risk Significance

Hard drusen: Small, discrete deposits with sharp borders. Usually lower risk when isolated.
Soft drusen: Larger deposits with indistinct borders that may become confluent. High-risk phenotype for AMD progression.
Drusenoid PED: Elevation of the RPE caused by confluent soft drusen. Indicates substantial drusen burden, intermediate AMD and increased risk of progression to late AMD.

4 Facts Exams Always Ask

Small drusen measure less than 63 µm, medium drusen measure 63-124 µm and large drusen measure 125 µm or greater.
Soft drusen are the high-risk phenotype because their indistinct borders and confluence signal greater AMD progression risk.
AMD staging depends heavily on drusen size and type, with large soft drusen supporting intermediate AMD.
Recommend AREDS2 supplementation for intermediate AMD in one or both eyes or advanced AMD in one eye, not early AMD alone.

The Classic Trap

Do not equate every visible druse with the same AMD risk. Hard drusen are typically small and sharply demarcated, whereas soft drusen are larger with indistinct borders. The board answer is driven by soft morphology, large size and confluence, not simply by the presence of drusen.

Clinical Pearl

Large soft confluent drusen indicate intermediate AMD. Counsel these patients about AREDS2 supplementation when criteria are met and Amsler grid monitoring for new distortion or central visual change.

Check yourself

Checkpoint 1

Which finding is sufficient to classify an eye as having intermediate AMD?

Checkpoint 2

Which office or home monitoring tool is specifically mentioned for detecting new-onset neovascular AMD changes?

Clinical case

A 72-year-old patient has bilateral macular deposits measuring 150 µm. The deposits have indistinct borders and merge in several areas. There is no history of advanced AMD in either eye. Which AMD stage and management discussion best fit these findings?

A patient with known intermediate AMD develops an acute drop in central vision and metamorphopsia. Which progression should be most strongly suspected?

Explanation

Exudative or neovascular AMD is associated with acute to subacute vision loss and metamorphopsia. New fluid, hemorrhage, or choroidal neovascularization should be considered in this setting.

Case discussion

The large size, soft borders and confluence identify a high-risk drusen pattern consistent with intermediate AMD. Discuss AREDS2 supplementation and Amsler grid monitoring because this patient meets the clinical profile taught above.

Sources & Reviewer Info

Reviewed by Vasilis Inglezis: Optometrist and Ocular Oncology Imaging Specialist, Ocular Oncology Center, Athens, Greece. Last updated August 2, 2026.

References

American Academy of Ophthalmology. Basic and Clinical Science Course, Section 12: Retina and Vitreous.
American Academy of Ophthalmology. EyeWiki: Age-Related Macular Degeneration.
Ryan SJ, et al. Ryan's Retina.

Continue learning

Ready for the real thing?

Practice thousands of eye-care questions free on OcuQuiz. Earn points, build streaks and battle colleagues.

Practice Retina →